| 1 |
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in globocan 2012[J]. Int J Cancer，2015，136(5): 359-386.
|
| 2 |
Kitano S, Iso Y, Moriyama M，et al. Laparoscopy-assisted Billroth I gastrectomy[J]. Surg Laparosc Endosc，1994，4(2): 146-148.
|
| 3 |
Uyama I, Sugioka A, Fujita J，et al. Laparoscopic total gastrectomy with distal pancreatosplenectomy and D2 lymphadenectomy for advanced gastric cancer[J]. Gastric Cancer，1999，2(4): 230-234.
|
| 4 |
Hu Y, Huang C, Sun Y, et al. Morbidity and mortality of laparoscopic versus open D2 distal gastrectomy for advanced gastric cancer: a randomized controlled trial[J]. Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology, 2016, 34(12): 1350-1357.
|
| 5 |
Yu J, Huang C, Sun Y，et al. Effect of laparoscopic vs open distal gastrectomy on 3-year disease-free survival in patients with locally advanced gastric cancer: the class-01 randomized clinical trial[J]. JAMA，2019，321(20): 1983-1992.
|
| 6 |
Dubecz A, Solymosi N, Stadlhuber RJ, et al. Does the incidence of adenocarcinoma of the esophagus and gastric cardia continue to rise in the twenty-first century-a seer database analysis[J]. Journal of Gastrointestinal Surgery, 2014, 18(1): 124-129.
|
| 7 |
Yamashita H, Seto Y, Sano T, et al. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma[J]. Gastric Cancer，2017，20(1): 69-83.
|
| 8 |
Siewert JR, Hölscher AH, Becker K, et al. Cardia cancer: attempt at a therapeutically relevant classification[J]. Chirurg, 1987, 58(1): 25-32.
|
| 9 |
Siewert JR, Stein HJ. Classification of adenocarcinoma of the esophagogastric junction[J]. BR J Surg，1998，85(11): 1457-1459.
|
| 10 |
袁勇，陈心足，胡建昆，等. 食管胃结合部腺癌外科治疗中国专家共识(2018年版)解读[J]. 中华胃肠外科杂志，2019，22(2): 101-106.
|
| 11 |
Sasako M, Sano T, Yamamoto S, et al. Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial[J]. Lancet Oncol，2006，7(8): 644-651.
|
| 12 |
Feith M, Stein HJ, Siewert JR. Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients[J]. Surg Oncol Clin N Am，2006，15(4): 751-764.
|
| 13 |
Kurokawa Y, Takeuchi H, Doki Y, et al. Mapping of lymph node metastasis from esophagogastric junction tumors: a prospective nationwide multicenter study[J]. Ann Surg，2019 Aug 8. doi:
10.1097/SLA.0000000000003499.[Epub ahead of print]
|
| 14 |
Mariette C, Piessen G, Briez N, et al. Oesophagogastric junction adenocarcinoma: which therapeutic approach[J]．Lancet Oncol，2011，12(3): 296-305.
|
| 15 |
Mine S, Sano T, Hiki N, et al. Proximal margin length with transhiatal gastrectomy for siewert type Ⅱ and Ⅲ adenocarcinomas of the oesophagogastric junction[J]. Br J Surg，2013，100(8): 1050-1054.
|
| 16 |
Siu KF, Cheung HC, Wong J. Shrinkage of the esophagus after resection for carcinoma[J]. Ann Surg，1986，203(2): 173-176.
|
| 17 |
Mine S, Kurokawa Y, Takeuchi H, et al. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in siewert type Ⅱ tumors[J]. Eur J Surg Oncol，2015，41(10): 1348-1353.
|
| 18 |
Hong J, Qian L, Wang YP, et al. A novel method of delta-shaped intracorporeal double-tract reconstruction in totally laparoscopic proximal gastrectomy[J]. Surg Endosc，2016，30(6): 2396-2403.
|
| 19 |
Hong J, Wang YP, Wang J, et al. A novel method of self-pulling and latter transected reconstruction in totally laparoscopic total gastrectomy: feasibility and short-term safety[J]. Surg Endosc，2017，31(7): 2968-2976.
|
| 20 |
蒿汉坤，洪军，王雅平，等. 自牵引后离断食管-空肠吻合术100例安全性评价[J]. 中华胃肠外科杂志，2018，21(2): 206-211.
|